Metastatic Salivary Duct Carcinoma with ERBB2 Amplification and Sequential Response to Ado-Trastuzumab Emtansine and Neratinib: A Case Report
Case reports in oncology(2023)
Key words
ERBB2,Salivary duct carcinoma,Neratinib,Electronically captured patient-reported outcomes,Case report
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined